Sounds like great progress was made with chronic kidney disease. Chronic kidney disease almost always accompanies heart disease.
This study reveals that corisin, a peptide produced by gut bacteria, plays a significant role in the progression of diabetic kidney fibrosis. Researchers found elevated levels of corisin in the blood of diabetic patients with chronic kidney disease, which correlated with the severity of their condition and declining kidney function. The study demonstrates that corisin travels to the kidneys by binding to serum albumin and once there, it accelerates cellular aging, promotes harmful cellular transitions, and induces cell death, all of which worsen kidney fibrosis. Importantly, in a mouse model of the disease, treatment with a monoclonal antibody that neutralizes corisin was shown to significantly reduce the severity of the kidney damage, suggesting that targeting corisin could be a promising new therapeutic strategy for diabetic nephropathy.
